These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 34769106)

  • 21. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
    Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
    Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dialog between neurons and microglia in Alzheimer's disease: The neurotransmitters view.
    Stolero N; Frenkel D
    J Neurochem; 2021 Sep; 158(6):1412-1424. PubMed ID: 33314073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GABA-containing compound gammapyrone protects against brain impairments in Alzheimer's disease model male rats and prevents mitochondrial dysfunction in cell culture.
    Pilipenko V; Narbute K; Amara I; Trovato A; Scuto M; Pupure J; Jansone B; Poikans J; Bisenieks E; Klusa V; Calabrese V
    J Neurosci Res; 2019 Jun; 97(6):708-726. PubMed ID: 30742328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer's disease.
    Park JS; Kam TI; Lee S; Park H; Oh Y; Kwon SH; Song JJ; Kim D; Kim H; Jhaldiyal A; Na DH; Lee KC; Park EJ; Pomper MG; Pletnikova O; Troncoso JC; Ko HS; Dawson VL; Dawson TM; Lee S
    Acta Neuropathol Commun; 2021 Apr; 9(1):78. PubMed ID: 33902708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microglial Calhm2 regulates neuroinflammation and contributes to Alzheimer's disease pathology.
    Cheng J; Dong Y; Ma J; Pan R; Liao Y; Kong X; Li X; Li S; Chen P; Wang L; Yu Y; Yuan Z
    Sci Adv; 2021 Aug; 7(35):. PubMed ID: 34433553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microglia in Alzheimer's Disease: A Favorable Cellular Target to Ameliorate Alzheimer's Pathogenesis.
    Sumsuzzman DM; Uddin MS; Kabir MT; Hasana S; Perveen A; Alanazi IS; Albadrani GM; Abdel-Daim MM; Ashraf GM
    Mediators Inflamm; 2022; 2022():6052932. PubMed ID: 35693110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
    Streit WJ; Braak H; Xue QS; Bechmann I
    Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterozygous CX3CR1 Deficiency in Microglia Restores Neuronal β-Amyloid Clearance Pathways and Slows Progression of Alzheimer's Like-Disease in PS1-APP Mice.
    Hickman SE; Allison EK; Coleman U; Kingery-Gallagher ND; El Khoury J
    Front Immunol; 2019; 10():2780. PubMed ID: 31849963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deficient astrocyte metabolism impairs glutamine synthesis and neurotransmitter homeostasis in a mouse model of Alzheimer's disease.
    Andersen JV; Christensen SK; Westi EW; Diaz-delCastillo M; Tanila H; Schousboe A; Aldana BI; Waagepetersen HS
    Neurobiol Dis; 2021 Jan; 148():105198. PubMed ID: 33242587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
    Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
    J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microglia in Alzheimer's Disease: An Unprecedented Opportunity as Prospective Drug Target.
    Kulkarni B; Cruz-Martins N; Kumar D
    Mol Neurobiol; 2022 May; 59(5):2678-2693. PubMed ID: 35149973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review on Cross Talk between Neurotransmitters and Neuroinflammation in Striatum and Cerebellum in the Mediation of Motor Behaviour.
    Abg Abd Wahab DY; Gau CH; Zakaria R; Muthu Karuppan MK; A-Rahbi BS; Abdullah Z; Alrafiah A; Abdullah JM; Muthuraju S
    Biomed Res Int; 2019; 2019():1767203. PubMed ID: 31815123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenosine A
    Franco R; Rivas-Santisteban R; Casanovas M; Lillo A; Saura CA; Navarro G
    Cells; 2020 Apr; 9(5):. PubMed ID: 32357548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease.
    Rodriguez-Perdigon M; Tordera RM; Gil-Bea FJ; Gerenu G; Ramirez MJ; Solas M
    Hippocampus; 2016 Oct; 26(10):1303-12. PubMed ID: 27258819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microglia receptors and their implications in the response to amyloid β for Alzheimer's disease pathogenesis.
    Doens D; Fernández PL
    J Neuroinflammation; 2014 Mar; 11():48. PubMed ID: 24625061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer's disease.
    Park J; Wetzel I; Marriott I; Dréau D; D'Avanzo C; Kim DY; Tanzi RE; Cho H
    Nat Neurosci; 2018 Jul; 21(7):941-951. PubMed ID: 29950669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease.
    Fang F; Lue LF; Yan S; Xu H; Luddy JS; Chen D; Walker DG; Stern DM; Yan S; Schmidt AM; Chen JX; Yan SS
    FASEB J; 2010 Apr; 24(4):1043-55. PubMed ID: 19906677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuronal and astrocytic metabolism in a transgenic rat model of Alzheimer's disease.
    Nilsen LH; Witter MP; Sonnewald U
    J Cereb Blood Flow Metab; 2014 May; 34(5):906-14. PubMed ID: 24594625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microglial Activation in the Retina of a Triple-Transgenic Alzheimer's Disease Mouse Model (3xTg-AD).
    Salobrar-García E; Rodrigues-Neves AC; Ramírez AI; de Hoz R; Fernández-Albarral JA; López-Cuenca I; Ramírez JM; Ambrósio AF; Salazar JJ
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.
    Lee S; Varvel NH; Konerth ME; Xu G; Cardona AE; Ransohoff RM; Lamb BT
    Am J Pathol; 2010 Nov; 177(5):2549-62. PubMed ID: 20864679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.